Inclisiran Formulation
1 clinical trials · Condition
◉ Watch Inclisiran Formulation
| Record | Firm | Date |
|---|---|---|
| Assessment of Safety, Tolerability, Pharmacokinetics and Pharmacodynamics of a New Formulation of Inclisiran Containing Polysorbate 80 Compared to the Currently Marketed Formulation (NCT07626281) | Novartis Pharmaceuticals | 2026-06-09 |
Track Inclisiran Formulation automatically
Every clearance here is in the API, with alerts when new ones post.